Endoscopic treatments of obesity and metabolic disease: Are we there yet?;Tratamiento endoscópico de la obesidad y los trastornos metabólicos: ¿una realidad?

Revista Espanola de Enfermedades Digestivas

Volumn 106, Issue 7, 2014, Pages 467-476

  Abu Dayyeh, Barham K ^a   Sarmiento, Ray ^a   Rajan, Elizabeth ^a   Vázquez Sequeiros, Enrique ^b   Gostout, Christopher J ^a  

^a MAYO CLINIC   (United States)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Endoscopy; Obesity; Therapy

Indexed keywords

ABDOMINAL PAIN; ARTICLE; ASPIRATION; BARIATRIC SURGERY; BODY WEIGHT DISORDER; DIABETES MELLITUS; DOUBLE BALLOON; ENDOCINCH; ENDOSCOPIC THERAPY; EPIGASTRIC FULLNESS; FULL SENSE DEVICE; GASTRECTOMY; GASTRIC BALLOON; GASTROPLASTY; HUMAN; LAPAROSCOPY; LIFESTYLE MODIFICATION; MEDICAL DEVICE; MEDICAL DEVICE COMPLICATION; META ANALYSIS (TOPIC); METABOLIC DISORDER; METABOLIC SYNDROME X; NAUSEA AND VOMITING; NONALCOHOLIC FATTY LIVER; OBESITY; PRIMARY OBESITY SURGERY ENDOLUMENAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SATIETY; SMALL INTESTINE OBSTRUCTION; STOMACH BYPASS; TRANSORAL ENDOSCOPIC RESTRICTIVE SYSTEM; VAGUS NERVE STIMULATION; ENDOSCOPY; METABOLIC DISEASES; MORBID OBESITY; PROCEDURES; SMALL INTESTINE; STOMACH;

BARIATRIC SURGERY; ENDOSCOPY; GASTRIC BALLOON; HUMANS; INTESTINE, SMALL; METABOLIC DISEASES; OBESITY; OBESITY, MORBID; STOMACH;

EID: 84928986970     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-41.
2. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224-60.
3. Ong JP, Younossi ZM. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 2007;11:1-16.
4. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology 2005;129:113-21.
5. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health 2009;9:88.
6. Anderson JW, Konz EC, Frederich RC, Wood CL. Long-term weightloss maintenance: A meta-analysis of US studies. The American Journal of Clinical Nutrition 2001;74:579-84.
7. Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med 2011;365:1597-604.
8. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: A systematic review and meta-analysis. JAMA 2004;292:1724-37.
9. Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: An updated systematic review and meta-analysis, 2003-2012. JAMA Surgery 2013 (doi: 10.1001/jamasurg.2013.3654).
10. Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial-A prospective controlled intervention study of bariatric surgery. J Intern Med 2013;273:219-34.
11. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg 2013;23:427-36.
12. Abu Dayyeh BK, Thompson CC. Obesity and bariatrics for the endoscopist: New techniques. Therap Adv Gastroenterol 2011;4:433-42.
13. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012;366:1567-76.
14. Peterli R, Steinert RE, Woelnerhanssen B, Peters T, Christoffel-Courtin C, Gass M, et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: A randomized, prospective trial. Obes Surg 2012;22:740-8.
15. Hogan RB, Johnston JH, Long BW, Sones JQ, Hinton LA, Bunge J, et al. A double-blind, randomized, sham-controlled trial of the gastric bubble for obesity. Gastrointest Endosc 1989;35:381-5.
16. Fuller NR, Pearson S, Lau NS, Wlodarczyk J, Halstead MB, Tee HP, et al. An intragastric balloon in the treatment of obese individuals with metabolic syndrome: A randomized controlled study. Obesity 2013;21:1561-70.
17. Farina MG, Baratta R, Nigro A, Vinciguerra F, Puglisi C, Schembri R, et al. Intragastric balloon in association with lifestyle and/or pharmacotherapy in the long-term management of obesity. Obes Surg 2012;22:565-71.
18. Genco A, Cipriano M, Bacci V, Maselli R, Paone E, Lorenzo M, et al. Intragastric balloon followed by diet vs intragastric balloon followed by another balloon: A prospective study on 100 patients. Obes Surg 2010;20:1496-500.
19. Mathus-Vliegen EM, Tytgat G. Intragastric balloon for treatmentresistant obesity: Safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc 2005;61:19-27.
20. Lee YM, Low HC, Lim LG, Dan YY, Aung MO, Cheng CL, et al. Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: A pilot study. Gastrointest Endosc 2012;76:756-60.
21. Imaz I, Martínez-Cervell C, García-Álvarez EE, Sendra-Gutiérrez JM, González-Enríquez J. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg 2008;18:841-6.
22. Kotzampassi K, Grosomanidis V, Papakostas P, Penna S, Eleftheriadis E. 500 intragastric balloons: What happens 5 years thereafter? Obes Surg 2012;22:896-903.
23. Ponce J, Quebbemann BB, Patterson EJ. Prospective, randomized, multicenter study evaluating safety and efficacy of intragastric dualballoon in obesity. Surg Obes Relat Dis 2013;9:290-5.
24. Verdam FJ, Schouten R, Greve JW, Koek GH, Bouvy ND. An update on less invasive and endoscopic techniques mimicking the effect of bariatric surgery. J Obes 2012;2012:597871.
25. Familiari P, Costamagna G, Bléro D, Le Moine O, Perri V, Boskoski I, et al. Transoral gastroplasty for morbid obesity: A multicenter trial with a 1-year outcome. Gastrointest Endosc 2011;74:1248-58.
26. de Jong K, Mathus-Viegen EM, Veldhuyzen EA, Eshuis JH, Fockens P. Short-term safety and efficacy of the Trans-oral Endoscopic Restrictive Implant System for the treatment of obesity. Gastrointestinal Endoscopy 2010;72:497-504.
27. Fogel R, De Fogel J, Bonilla Y, De La Fuente R. Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc 2008;68:51-8.
28. B Brethauer SA, Chand B, Schauer PR, Thompson CC. Transoral gastric volume reduction as intervention for weight management: 12-month follow-up of TRIM trial. Surgm Obes Relat Dis 2012;8:296-303.
29. Espinós JC, Turró R, Mata A, Cruz M, da Costa M, Villa V, et al. Early experience with the Incisionless Operating Platform (IOP) for the treatment of obesity: The Primary Obesity Surgery Endolumenal (POSE) procedure. Obes Surg 2013;23:1375-83.
30. Abu Dayyeh BK, Rajan E, Gostout CJ. Endoscopic sleeve gastroplasty: A potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc 2013;78:530-5.
31. Sullivan S, Stein R, Jonnalagadda S, Mullady D, Edmundowicz S. Aspiration therapy leads to weight loss in obese subjects: A pilot study. Gastroenterology 2013;145:1245-52.
32. Gersin KS, Rothstein RI, Rosenthal RJ, Stefanidis D, Deal SE, Kuwada TS, et al. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc 2010;71:976-82.
33. Schouten R, Rijs CS, Bouvy ND, Hameeteman W, Koek GH, Janssen IM, et al. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg 2010;251:236-43.
34. Cohen RV, Neto MG, Correa JL, Sakai P, Martins B, Schiavon CA, et al. A pilot study of the duodenal-jejunal bypass liner in low body mass index type 2 diabetes. J Clin Endocrinol Metabol 2013;98:E279-82.
35. de Jonge C, Rensen SS, Verdam FJ, Vincent RP, Bloom SR, Buurman WA, et al. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes. Obesity Surgery 2013;23:1354-60.
36. de Jonge C, Rensen SS, Koek GH, Joosten MF, Buurman WA, Bouvy ND, et al. Endoscopic duodenal-jejunal bypass liner rapidly improves plasma parameters of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2013;11:1517-20.
37. Majumder S, Birk J. A review of the current status of endoluminal therapy as a primary approach to obesity management. Surg Endosc 2013;27:2305-11.
38. Mizrahi M, Ben Ya’acov A, Ilan Y. Gastric stimulation for weight loss. World J Gastroenterol 2012;18:2309-19.
39. Itoi T, Itokawa F, Uraoka T, Gotoda T, Horii J, Goto O, et al. Novel EUS-guided gastrojejunostomy technique using a new double-balloon enteric tube and lumen-apposing metal stent (with videos). Gastrointest Endosc 2013;78:934-9.
40. Ryou M, Cantillon-Murphy P, Azagury D, Shaikh SN, Ha G, Greenwalt I, et al. Smart Self-Assembling MagnetS for ENdoscopy (SAMSEN) for transoral endoscopic creation of immediate gastrojejunostomy (with video). Gastrointest Endosc 2011;73:353-9.